ARCHIVES

Guidelines Working Group Agrees On 4750,00 As Base; Steckel Says AACI May Object To “Freeze” On Core

This article is from The Cancer Letter archive.

Vol. 06 No. 46 | November 21, 1980

Download PDF Visit The Full Archive

Related Articles

NCI Cooperative Group, Cancer Center Trials Listed

October 28, 2005

ODAC Says Clear Clinical Benefit Required When Sponsors Claim Progression Delay

July 17, 2009

FDA Advisors Debate Ban, Black Box And Status Quo of Power Morcellators

July 25, 2014

FDA Proposes To Drop Specific Requirements For Reprint Distribution On Off-Label Uses.

February 22, 2008

Six Patients Apparently responded To Laetrile, NCI Review Finds; DCT Considers Clinical Trials

September 8, 1978

Drugs and Targets: Blincyto granted accelerated approval in R/R ALL

December 5, 2014